- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04833699
The Effect of Hot Pack Application on Postoperative Ileus Undergoing Surgery for Gynecologic Malignancies
The Effect of Hot Pack Application of Umbilical Region on Postoperative Ileus in Patients Undergoing Surgery for Gynecologic Malignancies: a Randomized Controlled Trial
Postoperative ileus (POI), is an extensively known complication characterized by an impairment of normal gastrointestinal motor activity after abdominal surgery and may also occur after surgery at other sites due to non-mechanical causes. [1]. This clinical asset has been linked to prominent perioperative morbidity with the following financial burden owing to extended hospitalization [1]. Furthermore, POI can postpone adjuvant treatments, such as chemotherapy in patients who went through surgery for cancers.
Abdominal tenderness and distension, nausea and vomiting, delay in the passage of flatus and stool, and intolerance to solid food are the prime symptoms of POI [1-3]. It is generally transient, but if prolonged, can cause surgical incision dehiscence, intestinal anastomotic fistula, abdominal cavity infection, intestinal ischemia, aspiration pneumonia, and other serious complications [4-6]. Hence, many clinicians have focused on averting POI. Many studies have analyzed preventive methods, such as preoperative mobilization of the patient, adequate pain control, gum chewing, epidural anesthesia, coffee consumption, and motility agents such as metoclopramide and alvimopan [7-15]. For all the manifold remedy approaches, POI maintains a difficult clinical challenge that compromises the rapid improvement of patients who underwent abdominal surgery.
Recently, thermal attempts have been employs for several situations such as inflammatory bowel disease, chronic pelvic pain, and abdominal pain [16]. It may be used in two different ways; whole body or local. Local thermal therapy can be carried out by hot pack or paraffin [17]. It has been demonstrated that local thermotherapy abate myotonia, enhances circulation, and eases pain by expediting the removal of the pain-producing substance. Local thermal therapy is widely used for a number of conditions such as pain, nausea, vomiting, and some bowel diseases in traditional Chinese medicine [18].
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mugla, Turkey, 48000
- Mugla Sıtkı Kocman University Education and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patiens aith aged ≥18 years olds
- patients undergoing elective exhaustive staging surgery (total hysterectomy (Type A-C2), systematic pelvic para-aortic lymphadenectomy ± bilateral salpingo-oophorectomy and ± omentectomy by abdominal approach containing either open or laparoscopic surgery.
Exclusion Criteria:
- ASA score >3,
- chronic constipation (defined as ≤2 bowel movements per week),
- inflammatory bowel disease,
- irritable bowel syndrome,
- compromised liver function,
- clinically significant cardiac arrhythmia,
- Thyroid disorder,
- History of abdominal bowel surgery,
- previous abdominal irradiation,
- previous neoadjuvant chemotherapy or hyperthermic intraperitoneal chemotherapy,
- Performed upper abdominal surgery
- The covid-19 positive test result,
- bowel anastomosis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study
Group B served as the hot pack group boiled tap water (80 °C) was put in a rubber water bag with a fluffy cover (Fig. 1), and placed on the patient's abdomen at 3, 6, 9, and 12 h after the surgical procedure for 30 minutes in addition to clinical standard postoperative care (ERAS protocol).
|
bboiled tap water (80 °C) was put in a rubber water bag with a fluffy cover (Fig. 1), and placed on the patient's abdomen at 3, 6, 9, and 12 h after the surgical procedure for 30 minutes in addition to clinical standard postoperative care (ERAS protocol)
|
|
No Intervention: Control
Group A or the control group did not pick up any therapy except our clinical standard postoperative care (ERAS protocol)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
time to the first passage of flatus after surgery
Time Frame: up to 72 hours
|
Patients were checked hourly for bowel sounds by auscultation and were asked to note the time of first flatus and defecation and to inform the clinical nurses or an assistant.
|
up to 72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The time to the first bowel movement
Time Frame: up to 72 hours
|
The time to the first bowel movement was referred to the time to the first audible bowel sound during routine postoperative care.
Patients were checked hourly for bowel sounds by auscultation and were asked to note the time of first flatus and defecation and to inform the clinical nurses or an assistant.
|
up to 72 hours
|
|
The time to tolerate a solid diet
Time Frame: Up to 5 days
|
The time to tolerate a solid diet was measured from the end of operation, referred to the time when the patient awoke from anesthesia, until the patient tolerated intake of solid food (any food that required chewing) without vomiting
|
Up to 5 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUGLA-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Ileus
-
University of Lausanne HospitalsCompletedNasogastric Tube | Ileus PostoperativeSwitzerland
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompleted
-
University Hospital, GhentUniversity GhentTerminated
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
Seoul National University HospitalCompletedPostoperative IleusKorea, Republic of
-
Alberta Children's HospitalWithdrawnPostoperative IleusCanada
-
University Hospital, AngersCompleted
-
Hospital Universitari de BellvitgeCompleted
-
Chinese University of Hong KongUnknownPostoperative IleusChina
-
Chinese University of Hong KongUnknownPostoperative IleusChina
Clinical Trials on rubber water bag
-
Betsie van GaalZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Chiayi Christian HospitalCompletedGestational Diabetes MellitusTaiwan
-
Fengmei LianNot yet recruitingObese Impaired Glucose Tolerance | Newly Diagnosed Obese Type 2 Diabetic Patients
-
University of Colorado, Colorado SpringsRecruitingHyperthermiaUnited States
-
Ruhr University of BochumCompletedCRPS | Unilateral Limb Pain of Origin Other Than CRPSGermany
-
Eskisehir Osmangazi UniversityCompletedClinical Nursing ResearchTurkey
-
Cook Group IncorporatedTerminatedDyspepsia | Gastroesophageal Reflux Disease | Heartburn | RegurgitationUnited States
-
Gazi UniversityRecruiting
-
Istituto Auxologico ItalianoUniversity of Turin, ItalyCompleted
-
Universitat Internacional de CatalunyaCompleted